1. Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023; 84(2): 191-206. https://doi.org/10.1016/j.eururo.2023.04.021
2.
Belkahla S, Nahvi I, Biswas S, Nahvi I, Ben Amor N. Advances and development of prostate cancer, treatment, and strategies: a systemic review. Front. Cell Dev. Biol. 2022; 10: 991330. https://doi.org/10.3389/fcell.2022.991330
3.
Rybak J, Magiera B, Magiera K. Prostate cancer – risk factors and prevention strategies. J Educ Health Sport. 2023; 21(1): 197-211. https://doi.org/10.12775/JEHS.2023.21.01.018
4.
Merriel SWD, Pocock L, Gilbert E, Creavin S, Walter FM, Spencer A, et al. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 2022; 20(1): 54. https://doi.org/10.1186/s12916-021-02230-y
5.
Rao AG, Dkhar W, Sharath S, Kadavigere R, Pradhan A. Knowledge, awareness and practice towards screening for prostate cancer: a systematic review and meta-analysis. Ethiop J Health Sci. 2023; 33(3): 547-554. https://doi.org/10.4314/ejhs.v33i3.19
6.
Vietri MT, D’elia G, Caliendo G, Resse M, Casamassimi A, Passariello L, et al. Hereditary prostate cancer: genes related, target therapy and prevention. Int J Mol Sci. 2021; 22: 3753. https://doi.org/10.3390/ijms22073753
7.
Posdzich P, Darr C, Hilser T, Wahl M, Herrmann K, Hadaschik B, et al. Metastatic Prostate cancer—a review of current treatment options and promising new approaches. Cancers. 2023; 15(2): 461. https://doi.org/10.3390/cancers15020461
8.
Williams IS, McVey A, Perera S, O'Brien JS, Kostos L, Chen K, et al. Modern paradigms for prostate cancer detection and management. Med J Aust. 2022; 217(8): 424-433. https://doi.org/10.5694/mja2.51722
9.
Wojciechowska U, Didkowska JA, Barańska K, Miklewska M, Michałek I, Olasek P, et al. Cancer in Poland in 2022 [Internet]. Warsaw: Polish National Cancer Registry; 2014. [access 2025 Feb 5]. Available from: https://onkologia.org.pl/sites/default/files/publications/2025-02/0_krn-2024-book-20250212-secured.pdf
10.
European Cancer Information System. Prostate cancer burden in EU-27 [Internet]. European Commission [access 2025 Feb 4]. Available from: https://visitors-centre.jrc.ec.europa.eu/en/media/infographics/prostate-cancer-burden-eu-27.
11.
Federation of Polish Entrepreneurs. [Report of health protection committee. Straight to the point about prostate: What changes should be made in the care system for patients with prostate cancer in Poland?] [Internet]. Warsaw: Federation of Polish Entrepreneurs; 2023 [access 2025 Jan 29]. Available from: https://federacjaprzedsiebiorcow.pl/wp-content/uploads/2023/05/Raport-FPP_Co-nalezy-zmienic-w-systemie-opieki-nad-chorymi-z-nowotworem-gruczolu-krokowego-w-Polsce.pdf (in Polish).
12.
Osowiecka K, Nawrocki S, Kurowicki M, Rucinska M. The waiting time of prostate cancer patients in Poland. Int J Environ Res Public Health. 2019; 16(3): 342. https://doi.org/10.3390/ijerph16030342
13.
Association for the Support of Patients with Sarcoma and Melanoma. [Why don't we get tested? Cancer prevention of Polish women and men. Report: 2022] [Internet]. Warsaw: Association for the Support of Patients with Sarcoma and Melanoma; 2022 [access 2025 Jan 29]. Available from: https://www.sarcoma.pl/media/raport-2022.pdf (in Polish).
14.
MedicalPress. [Almost half of Poles know too little about cancer prevention] [Internet]. MedicalPress; 2022 [access 2025 Jan 29]. Available from: https://medicalpress.pl/rynek/prawie-poowa-polakw-wie-za-mao-o-profilaktyce-nowotworowej_d5A4NxKRJj/ (in Polish).
15.
glospacjenta.pl [Internet]. Warszawa: Fundacja Polska Koalicja Pacjentów Onkologicznych. [Report: "Health? A man's thing!"] [access 2025 Jan 29]. Available from: https://glospacjenta.pl/public/file/RAPORT%20kampanii%20Zdrowie_M%C4%99ska%20Sprawa.pdf (in Polish).
16.
George D, Mallery P. IBM SPSS statistics 23 step by step: a simple guide and reference. New York: Routledge; 2016.
17.
Taylor KL, Shelby R, Kerner J, Redd W, Lynch J. Impact of undergoing prostate carcinoma screening on prostate carcinoma-related knowledge and distress. Cancer. 2002; 95(5): 1037-1044. https://doi.org/10.1002/cncr.10781
18.
Weinrich SP, Seger R, Miller BL, Davis C, Kim S, Wheeler C, et al. Knowledge of the limitations associated with prostate cancer screening among low-income men. Cancer Nurs. 2004; 27(6): 442-53. https://doi.org/10.1097/00002820-200411000-00003
19.
Capık C, Gözüm S. Development and validation of health beliefs model scale for prostate cancer screenings (HBM-PCS): evidence from exploratory and confirmatory factor analyses. Eur J Oncol Nurs. 2011; 15(5): 478-85. https://doi.org/10.1016/j.ejon.2010.12.003
20.
Chmielewski JP, Szenk P, Orczykowski T, Kordyzon M, Zieba E, Czarny-Działak M. Knowledge and barriers related to the prevention of prostate cancer among men. Health Prob Civil. Forthcoming 2024. https://doi.org/10.5114/hpc.2024.142912
21.
Alothman AM, Altamimi AF, Alhenaki AW, Almansour NM, Alhusaini AK, Alateeq F. The knowledge and attitude towards prostate cancer and screening practices among males in Saudi Arabia. J Family Med Prim Care. 2022; 11(6): 2637-2642. https://doi.org/10.4103/jfmpc.jfmpc_1802_21
22.
Schulman CC, Kirby R, Fitzpatrick JM. Awareness of prostate cancer among the general public: findings of an independent international survey. Eur Urol. 2003; 44(3): 294-302. https://doi.org/10.1016/S0302-2838(03)00200-8
23.
Ehwarieme TA, Josiah U. Assessment of knowledge and acceptance of prostate cancer screening among male employees of selected local governments in Benin City, Edo State. The Nigerian Health Journal. 2024; 24(2): 1228-1240. https://doi.org/10.60787/tnhj.v24i2.804.
24.
Musalli Z, Alobaid M, Aljahani A, Alqahtani M, Alshehri S, Altulaihi B. Knowledge, attitude, and practice toward prostate cancer and its screening methods among primary care patients in King Abdulaziz Medical City, Riyadh, Saudi Arabia. Cureus. 2021; 13(4): e14689. https://doi.org/10.7759/cureus.14689
25.
Wiafe E, Mensah KB, Mensah ABB, Bangalee V, Oosthuizen F. Knowledge of prostate cancer presentation, etiology, and screening practices among women: a mixed-methods systematic review. Syst Rev. 2021; 10: 138. https://doi.org/10.1186/s13643-021-01695-5
26.
Parker LA, Caballero-Romeu JP, Chilet-Rosell E, Hernandez-Aguado I, Gómez-Pérez L, Alonso-Coello P, et al. Knowledge and practices regarding prostate cancer screening in Spanish men: the importance of personal and clinical characteristics (PROSHADE study). Plos One. 2024. https://doi.org/10.1371/journal.pone.0303203
27.
Makungu ML, Mweya CN. Assessing knowledge, attitude and practice towards prostate cancer screening among males in Southwest Tanzania: a cross-sectional study. Cancer Treat Res Commun. 2023; 36: 100716. https://doi.org/10.1016/j.ctarc.2023.100716
28.
Adewoye KR, Aremu SK, Adegbiji WA, Achebe CC. Awareness, knowledge, and factors that influenced the uptake of screening tests for prostate cancer among men aged 40 and older in Ido-Ekiti, Ekiti State, Nigeria. J Public Health Afr. 2023; 14(4): 2134. https://doi.org/10.4081/jphia.2023.2134
29.
Cowman S, Cowman JG, Almumin A, Altailasan FAFM, Weathers E. Knowledge and attitudes of men in Bahrain toward prostate cancer. Seminars in Oncology Nursing. 2021; 37(3): 151-158. https://doi.org/10.1016/j.soncn.2021.151158
30.
Sosnowski R, Kuczkiewicz O, Moskal K, Kuncewicz P. Assessing men's knowledge of lower urinary tract symptoms. Przegląd Urologiczny. 2017; 5(105).
31.
Rymon Lipińska W, Nowicka-Sauer K. Illness perception and perceived benefits of illness among persons with type 1 diabetes. Health Psychology Report. 2023; 11(3): 200-212. https://doi.org/10.5114/hpr/153999
32.
Piotrkowska R, Kruk A, Krzemińska A, Mędrzycka-Dąbrowska W, Kwiecień-Jaguś K. Factors determining the level of acceptance of illness and satisfaction with life in patients with cancer. Healthcare. 2023; 11(8): 1168. https://doi.org/10.3390/healthcare11081168
33.
Wolanin A. Assessment and acceptance of cancer in prostate cancer patients. Palliative Medicine in Practice. 2022; 16(3): 134-141. https://doi.org/10.5603/PMPI.2022.0012
34.
Przydacz M, Chlosta M, Rajwa P, Chlosta P. Population-level prevalence, effect on quality of life, and treatment behavior for erectile dysfunction and premature ejaculation in Poland. Sci Rep. 2023; 13: 13168. https://doi.org/10.1038/s41598-023-39968-9
Copyright: © 2025 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
